-

Scientific divisions

WEHI houses 14 scientific divisions.

ACRF Cancer Biology and Stem Cells
Our division is focused on breast, lung, ovarian and rare cancers.
ACRF Chemical Biology Division
The ACRF Chemical Biology division aims to discover new medicines.
Advanced Technology and Biology
Our division uses advanced and emerging technologies to accelerate scientific discoveries.
Bioinformatics
Scientists in the Bioinformatics division use methods from mathematics, statistics, and computer science to solve problems in medical research.
Bioinformatics and Computational Biology
Scientists in the Bioinformatics and Computational Biology division develop new computational, statistical and AI strategies to interpret the huge amounts of “omics” data generated in biomedical research.
Blood Cells and Blood Cancer
Our division investigates the processes that drive normal blood cell development.
Clinical Discovery and Translation
The Clinical Discovery and Translation team works to turn laboratory discoveries into improved outcomes for patients.
Epigenetics and Development
Researchers in our division study how cell growth and differentiation is regulated in normal development and in disease.
Immunology
Members of the Immunology division are dedicated to finding out how the immune system works and how it might be manipulated to achieve new disease treatments.
Infection and Global Health
Our division aims to gain knowledge and make discoveries that will aid in the prevention, treatment and management of infectious diseases.
Infectious Diseases and Immune Defence
Our division aims to gain knowledge and make discoveries that will aid in the prevention, treatment and management of infectious diseases.
Inflammation
Inflammation is the body’s natural response to infection, disease and tissue damage. However, ongoing or misdirected inflammation underlies many diseases.
New Medicines and Diagnostics
We use structural, chemical and molecular biology approaches along with medicinal chemistry and high-throughput screening, to discover new therapeutics.
Personalised Oncology
In the Personalised Oncology division clinicians and scientists are working together to reduce the impact of cancer in our community.
Population Health and Immunity
Our division uses population-based and experimental studies to investigate human biology and disease.
Structural Biology
Our division focuses on discovering new medicines through studies of the three-dimensional structure of large biological molecules that are either targets for drugs or potential therapeutic agents.
Ubiquitin Signalling
Proteins are the fundamental building blocks of cells. They are continuously modified, which alters their function and potential for causing disease.
Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Spring 2024
View the current issue